Adaptive Biotechnologies Corporation logo

Adaptive Biotechnologies Corporation (ADPT)

Market Closed
16 Oct, 08:00 PM
NASDAQ (NGS) NASDAQ (NGS)
$
24. 02
-1.56
-6.0985%
$
3.83B Market Cap
- P/E Ratio
- Div Yield
1.95M Volume
-1.38 Eps
$ 25.58
Previous Close
Add Transaction
Day Range
23.95 25.65
Year Range
12 30.74
Want to track ADPT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Adaptive Biotechnologies Corporation (ADPT) Statistics

Valuation metrics

Market Cap 3.83B
Enterprise value 4.07B
Trailing P/E (ttm) -58.96
Forward P/E -52.91
PEG ratio -1.17
Price/Sales (ttm) 12.44
Price/Book (mrq) 26.51
Enterprise Value/Revenue 13.22
Enterprise Value/EBITDA -255.24

Overview

Shares outstanding 153.78M
Float 118.71M
Shares short 8.56M
% Held by insiders 0.02%
% Held by institutions 1%
Average volume (10 days) 2.12M
Average volume (90 days) 2.33M

Price summary

52-Week low 12
52-Week high 30.74
Beta 2.3
50-Day moving average 26.51
200-Day moving average 20.52

Dividends and splits

Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:4
Last split Date 15 Jul 2026

Financials

Fiscal year

Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025

Profitability

Profit margin -0.21%
Operating margin -0.12%

Operational effectiveness

Return on assets -0.1%
Return on equity -0.33%

Income Statement

Revenue (ttm) 276.98M
Revenue per share (ttm) 1.95
Quarterly revenue growth (yoy) 0.51%
Gross profit (ttm) 205.62M
EBITDA -39.29M
Net income to common (ttm) -59.5M
Diluted EPS (ttm) -0.4
Quarterly earnings growth (yoy) -

Balance Sheet

Total cash (mrq) 226.98M
Total cash per share (mrq) 2.18
Total debt (mrq) 210.36M
Total Debt/Equity (mrq) 2.87
Current ratio (mrq) 4.79%
Book value per share (mrq) 0.96

Cash Flow

Cash flow statement -45.99M
Levered free cash flow (LFCF) 950.88K